SE9500036D0 - formulation - Google Patents

formulation

Info

Publication number
SE9500036D0
SE9500036D0 SE9500036A SE9500036A SE9500036D0 SE 9500036 D0 SE9500036 D0 SE 9500036D0 SE 9500036 A SE9500036 A SE 9500036A SE 9500036 A SE9500036 A SE 9500036A SE 9500036 D0 SE9500036 D0 SE 9500036D0
Authority
SE
Sweden
Prior art keywords
formulation
Prior art date
Application number
SE9500036A
Other languages
Swedish (sv)
Inventor
Jack Spira
Lars Widlund
Thomas Oesterberg
Brita Sjoestroem
Marianne Mikaelsson
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9500036A priority Critical patent/SE9500036D0/en
Publication of SE9500036D0 publication Critical patent/SE9500036D0/en
Priority to IL11301099A priority patent/IL113010A/en
Priority to IL11301095A priority patent/IL113010A0/en
Priority to TW084102570A priority patent/TW400234B/en
Priority to CA002186126A priority patent/CA2186126C/en
Priority to JP52561695A priority patent/JP3939750B2/en
Priority to AT95914669T priority patent/ATE222770T1/en
Priority to DE69527966T priority patent/DE69527966T2/en
Priority to AU21560/95A priority patent/AU690666B2/en
Priority to EP95914669A priority patent/EP0772452B1/en
Priority to PCT/SE1995/000348 priority patent/WO1995026750A1/en
Priority to NZ283499A priority patent/NZ283499A/en
Priority to ES95914669T priority patent/ES2182899T3/en
Priority to US08/716,140 priority patent/US5925739A/en
Priority to PT95914669T priority patent/PT772452E/en
Priority to PL95316618A priority patent/PL180282B1/en
Priority to DK95914669T priority patent/DK0772452T3/en
Priority to BRPI9507227A priority patent/BRPI9507227B8/en
Priority to HU9602693A priority patent/HU223314B1/en
Priority to KR1019960705410A priority patent/KR100373882B1/en
Priority to NO19964081A priority patent/NO321139B1/en
Priority to FI963871A priority patent/FI118171B/en
Priority to MXPA/A/1996/004455A priority patent/MXPA96004455A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
SE9500036A 1994-03-31 1995-01-05 formulation SE9500036D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9500036A SE9500036D0 (en) 1995-01-05 1995-01-05 formulation
IL11301099A IL113010A (en) 1994-03-31 1995-03-16 Pharmaceutical formulation comprising factor viii with an activity of at least 500iu/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
IL11301095A IL113010A0 (en) 1994-03-31 1995-03-16 Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
TW084102570A TW400234B (en) 1994-03-31 1995-03-17 Pharmaceutical compositions for subcutaneous, intramuscular or intradermal administration containing coagulation factor VIII or factor IX and additive
KR1019960705410A KR100373882B1 (en) 1994-03-31 1995-03-31 Pharmaceutical formulations for subcutaneous, intramuscular or intradermal administration of factor X
PCT/SE1995/000348 WO1995026750A1 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
US08/716,140 US5925739A (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous intramuscular or intradermal administration of factor VIII
AT95914669T ATE222770T1 (en) 1994-03-31 1995-03-31 PHARMACEUTICAL PREPARATION FOR SUBCUTANEOUS, INTRAMUSCULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII
DE69527966T DE69527966T2 (en) 1994-03-31 1995-03-31 PHARMACEUTICAL PREPARATION FOR SUBCUTANEOUS, INTRAMUSULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII
AU21560/95A AU690666B2 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor VIII or factor IX
EP95914669A EP0772452B1 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii
CA002186126A CA2186126C (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
NZ283499A NZ283499A (en) 1994-03-31 1995-03-31 Haemophilia medicament; comprises coagulation factor viii or factor ix
ES95914669T ES2182899T3 (en) 1994-03-31 1995-03-31 PHARMACEUTICAL FORMULATION FOR SUBCUTANEOUS, INTRAMUSCULAR OR INTRADERMAL ADMINISTRATION OF FACTOR VIII.
JP52561695A JP3939750B2 (en) 1994-03-31 1995-03-31 Pharmaceutical preparation for subcutaneous, intramuscular or intradermal administration of coagulation factor VIII
PT95914669T PT772452E (en) 1994-03-31 1995-03-31 PHARMACEUTICAL FORMULA FOR SUBCUTANEOUS INTRAMUSCULAR OR INTRADERIC FACTOR VIII ADMINISTRATION
PL95316618A PL180282B1 (en) 1994-03-31 1995-03-31 Pharmaceutic preparation for subcutaneous, intramuscular and intradermal administration of factor viii or ix
DK95914669T DK0772452T3 (en) 1994-03-31 1995-03-31 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor VIII
BRPI9507227A BRPI9507227B8 (en) 1994-03-31 1995-03-31 pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration
HU9602693A HU223314B1 (en) 1994-03-31 1995-03-31 Pharmaceutical compositions for subcutaneous, intramuscular or intradermal administration of factor viii
FI963871A FI118171B (en) 1994-03-31 1996-09-27 Pharmaceutical formulation for the subcutaneous, intramuscular or intradermal administration of factor VIII
NO19964081A NO321139B1 (en) 1994-03-31 1996-09-27 Pharmaceutical preparation suitable for subcutaneous, intramuscular or intradermal administration.
MXPA/A/1996/004455A MXPA96004455A (en) 1994-03-31 1996-09-30 Pharmaceutical formulation for administracionsubcutanea, intramuscular or intradermica of factorviii or factor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9500036A SE9500036D0 (en) 1995-01-05 1995-01-05 formulation

Publications (1)

Publication Number Publication Date
SE9500036D0 true SE9500036D0 (en) 1995-01-05

Family

ID=20396754

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500036A SE9500036D0 (en) 1994-03-31 1995-01-05 formulation

Country Status (2)

Country Link
KR (1) KR100373882B1 (en)
SE (1) SE9500036D0 (en)

Also Published As

Publication number Publication date
KR100373882B1 (en) 2003-08-02
KR970702064A (en) 1997-05-13

Similar Documents

Publication Publication Date Title
DK1093815T3 (en) Oral 2-methyl-thieno-benzodiazepine formulation
DE69620884T2 (en) KODEMULTIPLEXVIELFACHZUGRIFFSNACHRICHTENÜBERTRAGUNGSSYSTEM
DE69627553D1 (en) Lüftströmungssteuervorrichtung
DE69617471D1 (en) Hochgeschwindigkeitstraversiermechanismus
FI960845A0 (en) Strålapparatur
ATA181095A (en) PROBIOTALLY EFFECTIVE FORMULATION
DK0825860T3 (en) Prepare
DE69616611T2 (en) Ferritkernmarkierung
ATA135896A (en) SKIBOB
DE69624316D1 (en) Titenstrahldruckgerät
ITMI951395A0 (en) F-SILICONE FORMULATIONS
DE69631378D1 (en) PESTICIDAL FORMULATION
ATE198470T1 (en) ALKENYL-BENZOYLGUANIDINE
DE69630477D1 (en) Breitbandsignalkodierer
ATE240972T1 (en) CYCLOPEPTOLIDES
BR9611733A (en) Fluorobutenoyloxyacetamides
ATA119896A (en) Scheibenmähwerk
DE29504168U1 (en) Form set
SE9500036D0 (en) formulation
DE29510882U1 (en) Trestle
DE29512085U1 (en) Multisorter
NO970152D0 (en) Askorbylfosforylkolesterol
KR960030307U (en) again
DE29507813U1 (en) Trestle
FI2016U1 (en) Styrboggikonstruktion